Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Daidzein analogs as treatment for cancer

Daidzein analogs as treatment for cancer

US Patent 8962679 · Granted Feb 24, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrimidines for the targeted degradation of Bruton's tyrosine kinase2024
Methods of solvent removal at ambient temperatures—cryovap2024
Inhibitors of androgen receptor signaling2023
Anthranilic amides and the use thereof2022
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells2021
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells2021
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells2021
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells2021
Boronic derivatives of hydroxamates as anticancer agents2021
Boron-based prodrug strategy for increased bioavailability and lower-dosage requ2018
Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancer2018
Processes of synthesizing dihydropyridophthalazinone derivatives2018